Literature DB >> 27598222

Surface Strains of Porcine Tricuspid Valve Septal Leaflets Measured in Ex Vivo Beating Hearts.

Keyvan Amini Khoiy1, Dipankar Biswas2, Thomas N Decker3, Kourosh T Asgarian4, Francis Loth5, Rouzbeh Amini6.   

Abstract

Quantification of the tricuspid valve (TV) leaflets mechanical strain is important in order to understand valve pathophysiology and to develop effective treatment strategies. Many of the traditional methods used to dynamically open and close the cardiac valves in vitro via flow simulators require valve dissection. Recent studies, however, have shown that restriction of the atrioventricular valve annuli could significantly change their in vivo deformation. For the first time, the porcine valve leaflets deformation was measured in a passive ex vivo beating heart without isolating and remounting the valve annuli. In particular, the right ventricular apexes of porcine hearts (n = 8) were connected to a pulse-duplicator pump that maintained a pulsatile flow from and to a reservoir connected to the right atrium and the pulmonary arteries. This pump provided a right ventricular pressure (RVP) waveform that closely matched physiological values, leading to opening and closure of the tricuspid and pulmonary valves (PVs). At the midsection of the valve leaflets, the peak areal strain was 9.8 ± 2.0% (mean±standard error). The peak strain was 5.6 ± 1.1% and 4.3 ± 1.0% in the circumferential and radial directions, respectively. Although the right ventricle was beating passively, the leaflet peak areal strains closely matched the values measured in other atrioventricular valves (i.e., the mitral valve (MV)) in vivo. This technique can be used to measure leaflet strains with and without the presence of valve lesions to help develop/evaluate treatment strategies to restore normal valve deformation.

Entities:  

Mesh:

Year:  2016        PMID: 27598222     DOI: 10.1115/1.4034621

Source DB:  PubMed          Journal:  J Biomech Eng        ISSN: 0148-0731            Impact factor:   2.097


  7 in total

1.  Novel In Vitro Test Systems and Insights for Transcatheter Mitral Valve Design, Part I: Paravalvular Leakage.

Authors:  Eric L Pierce; Vahid Sadri; Beatrice Ncho; Keshav Kohli; Siddhi Shah; Ajit P Yoganathan
Journal:  Ann Biomed Eng       Date:  2018-10-17       Impact factor: 3.934

2.  A pilot in silico modeling-based study of the pathological effects on the biomechanical function of tricuspid valves.

Authors:  Devin W Laurence; Emily L Johnson; Ming-Chen Hsu; Ryan Baumwart; Arshid Mir; Harold M Burkhart; Gerhard A Holzapfel; Yi Wu; Chung-Hao Lee
Journal:  Int J Numer Method Biomed Eng       Date:  2020-05-08       Impact factor: 2.747

3.  Dilation of tricuspid valve annulus immediately after rupture of chordae tendineae in ex-vivo porcine hearts.

Authors:  Keyvan Amini Khoiy; Kourosh T Asgarian; Francis Loth; Rouzbeh Amini
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

Review 4.  Mechanics of the Tricuspid Valve-From Clinical Diagnosis/Treatment, In-Vivo and In-Vitro Investigations, to Patient-Specific Biomechanical Modeling.

Authors:  Chung-Hao Lee; Devin W Laurence; Colton J Ross; Katherine E Kramer; Anju R Babu; Emily L Johnson; Ming-Chen Hsu; Ankush Aggarwal; Arshid Mir; Harold M Burkhart; Rheal A Towner; Ryan Baumwart; Yi Wu
Journal:  Bioengineering (Basel)       Date:  2019-05-22

5.  Mechanical Response Changes in Porcine Tricuspid Valve Anterior Leaflet Under Osmotic-Induced Swelling.

Authors:  Samuel D Salinas; Margaret M Clark; Rouzbeh Amini
Journal:  Bioengineering (Basel)       Date:  2019-08-15

6.  An in-silico benchmark for the tricuspid heart valve - Geometry, finite element mesh, Abaqus simulation, and result data set.

Authors:  Devin W Laurence; Chung-Hao Lee; Emily L Johnson; Ming-Chen Hsu
Journal:  Data Brief       Date:  2021-12-02

7.  A Single-opening&closing Valve Tester for Direct Measurement of Closing Volume of the Heart Valve.

Authors:  Hao Wang; Zhan Cui; Zhongxi Zhou; Zhaoming He
Journal:  Cardiovasc Eng Technol       Date:  2021-06-25       Impact factor: 2.495

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.